Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-3353.71%Return on Equity
VS
Market
Sector
Industry
History
$ 1.65Close
$ 1.13 - $ 6.52 52-Week Range
Ticker Information
Ticker
TELOCompany Name
TELOMIR PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTELOMIR PHARMACEUTICALS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TELO - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 481.22K | $ -16.14M | -3353.71% |
| 3/31/2025 | $ -161.11K | $ -12.52M | 0% |
| 12/31/2024 | $ 643.04K | $ -16.53M | -2571.04% |
| 9/30/2024 | $ 442.07K | $ -23.02M | -5207.63% |
| 6/30/2024 | $ 1.57M | $ -18.74M | -1195.62% |
| 3/31/2024 | $ 3.02M | $ 0 | 0% |
| 12/31/2023 | $ 3.44M | $ -13.07M | -380.19% |
| 9/30/2023 | $ 2.18M | $ 0 | 0% |
| 12/31/2022 | $ -937.28K | $ -854.15K | 0% |
Key Performance Insights, Last 5 Years
- TELOMIR PHARMACEUTICALS INC's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, TELOMIR PHARMACEUTICALS INC's average ROE has been -2541.64%.
- The median ROE for TELOMIR PHARMACEUTICALS INC during this period was -2571.04%
- TELOMIR PHARMACEUTICALS INC reached its highest ROE over the past 5 years at -380.19%.
- The lowest ROE recorded by TELOMIR PHARMACEUTICALS INC in the same timeframe -5207.63%
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for TELOMIR PHARMACEUTICALS INC is calculated as follows: Net Inc. Cmn. [ $ -854.15K ] / Equity [ $ -937.28K ]
(=) ROE [ 0% ] TELO - Return on Equity, Last 5 years
-5207.63%
Minimum
Sep 30, 2024
-380.19%
Maximum
Dec 31, 2023
-2541.64%
Average
-2571.04%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |